These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 24858366)

  • 21. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
    Long JZ; Li W; Booker L; Burston JJ; Kinsey SG; Schlosburg JE; Pavón FJ; Serrano AM; Selley DE; Parsons LH; Lichtman AH; Cravatt BF
    Nat Chem Biol; 2009 Jan; 5(1):37-44. PubMed ID: 19029917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and FAAH(+/+) mice.
    Wiley JL; Lefever TW; Pulley NS; Marusich JA; Cravatt BF; Lichtman AH
    Behav Pharmacol; 2016 Aug; 27(5):479-84. PubMed ID: 27385208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
    Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
    Minkkilä A; Saario S; Nevalainen T
    Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
    Pertwee RG
    Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice.
    Walentiny DM; Gamage TF; Warner JA; Nguyen TK; Grainger DB; Wiley JL; Vann RE
    Eur J Pharmacol; 2011 Apr; 656(1-3):63-7. PubMed ID: 21300050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
    Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
    Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
    Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
    Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of tetrahydrocannabinol on the endocannabinoid 2-arachidonoylglycerol metabolism: ABHD6 and ABHD12 as novel players in human placenta.
    Maia J; Fonseca BM; Cunha SC; Braga J; Gonçalves D; Teixeira N; Correia-da-Silva G
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158807. PubMed ID: 32829065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.
    Pan B; Wang W; Long JZ; Sun D; Hillard CJ; Cravatt BF; Liu QS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):591-7. PubMed ID: 19666749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
    Limebeer CL; Abdullah RA; Rock EM; Imhof E; Wang K; Lichtman AH; Parker LA
    Psychopharmacology (Berl); 2014 Feb; 231(3):603-12. PubMed ID: 24043345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
    Ho WS; Randall MD
    Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
    Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
    Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical probes of endocannabinoid metabolism.
    Blankman JL; Cravatt BF
    Pharmacol Rev; 2013 Apr; 65(2):849-71. PubMed ID: 23512546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the endocannabinoid system by organophosphorus nerve agents.
    Nomura DK; Blankman JL; Simon GM; Fujioka K; Issa RS; Ward AM; Cravatt BF; Casida JE
    Nat Chem Biol; 2008 Jun; 4(6):373-8. PubMed ID: 18438404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.
    Nader J; Rapino C; Gennequin B; Chavant F; Francheteau M; Makriyannis A; Duranti A; Maccarrone M; Solinas M; Thiriet N
    Neuropharmacology; 2014 Dec; 87():214-21. PubMed ID: 24709540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
    Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
    Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
    Lau BK; Drew GM; Mitchell VA; Vaughan CW
    Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.